These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31847536)

  • 1. Improved clinical outcomes among persons with HIV who quit smoking.
    Lubitz SF; Flitter A; Ashare RL; Thompson M; Leone F; Gross R; Schnoll R
    AIDS Care; 2020 Oct; 32(10):1217-1223. PubMed ID: 31847536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of varenicline adherence among smokers with HIV and its association with smoking cessation.
    Quinn MH; Bauer AM; Flitter A; Lubitz SF; Ashare RL; Thompson M; Leone F; Gross R; Schnoll R
    Addict Behav; 2020 Mar; 102():106151. PubMed ID: 31783245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of varenicline on mood and cognition in smokers with HIV.
    Thompson M; Schnoll R; Serrano K; Leone F; Gross R; Collman RG; Ashare RL
    Psychopharmacology (Berl); 2020 Apr; 237(4):1223-1231. PubMed ID: 31938877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediators of the effect of nicotine pre-treatment on quitting smoking.
    Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
    Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking among Chinese PLWHA: An exploration of changes in smoking after being tested HIV positive.
    Wang Y; Chen X; Li X; Wang Y; Shan Q; Zhou Y; Shen Z
    AIDS Care; 2016; 28(3):365-9. PubMed ID: 26457812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
    Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking Cessation.
    Crawford G; Weisbrot J; Bastian J; Flitter A; Jao NC; Carroll A; Kalhan R; Leone F; Hitsman B; Schnoll R
    Nicotine Tob Res; 2019 Jul; 21(8):1135-1139. PubMed ID: 29955828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
    Schnoll R; Leone F; Veluz-Wilkins A; Miele A; Hole A; Jao NC; Paul Wileyto E; Carroll AJ; Kalhan R; Patel J; Langer C; Lubitz SF; Hitsman B
    Psychooncology; 2019 Mar; 28(3):561-569. PubMed ID: 30680852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
    Anthenelli RM; Gaffney M; Benowitz NL; West R; McRae T; Russ C; Lawrence D; St Aubin L; Krishen A; Evins AE
    J Gen Intern Med; 2019 Jun; 34(6):862-870. PubMed ID: 30847828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation.
    Tesoriero JM; Gieryic SM; Carrascal A; Lavigne HE
    AIDS Behav; 2010 Aug; 14(4):824-35. PubMed ID: 18777131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM
    JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.